IRON Intrinsic Valuation and Fundamental Analysis - Disc Medicine Inc

Watchlist Manager

Watchlist

Price: 82.84 USD -0.43% Market Closed

Market Cap: $3.2B

	Disc Medicine Inc NASDAQ:IRON	US
	Almonty Industries Inc F:ALI1	CA

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value for Disc Medicine Inc.

Do our valuations actually work? See backtest results .

Fundamental Analysis

What Disc Medicine Does

Biotechnology Health Care

Disc Medicine is a biopharmaceutical company focused on blood disorders, especially diseases tied to how the body makes red blood cells and handles iron. It does not sell a broad lineup of products; instead, it develops drug candidates that aim to treat serious conditions caused by problems with hemoglobin, iron balance, and red blood cell production.

Headquarters: United States of America US
Employees: 155
IPO date: Aug 12, 2020

Read the full company overview

How Disc Medicine makes money

Drug development

Disc Medicine develops medicines for blood disorders, with a focus on diseases linked to how the body uses and controls iron. The company runs research, lab work, and clinical trials to turn drug candidates into approved treatments.

Customers: Patients with hematologic diseases, through doctors, hospitals, and specialty clinics; if it partners with larger drug companies, those partners can also use or help commercialize its programs.
Revenue Model: It would make money by selling approved drugs, and it may also earn income from research collaborations, licensing deals, or milestone payments from partners.

View Company Overview